banner

Författare: Silfverdal Sven Arne

Titel: Vaccination ger bra immunsvar hos barn (serie: Tema barnvaccinationer) 2008 nr 22 sid 1670-4

Läs/ladda hem artikeln:
Översikt
Fullständig referenslista
Artikeln i pdf-format
Artikeln i webbversion
Sid 1670
Sid 1671
Sid 1672
Sid 1673
Sid 1674
Om Läkartidningens fulltext på Internet
Ämnesord:
Antikroppsbildning
Immuniseringsprogram
Immuniseringsschema
Bakteriella vacciner
Virusvacciner
Nyfödda















Sök liknande artiklar

Referenser:
1.Hanson LÅ, Silfverdal SA. Fostrets och den nyföddes immunsystem. Lagercranz H, redaktör. Neonatologi. Lund: Studentlitteratur. p. 289-310. Under tryckning.
2.West LJ. Defining critical windows in the development of the human immune system. Hum Exp Toxicol. 2002;21(9-10):499-505.
3.Maródi L. Innate cellular immune responses in newborns. Clin Immunol. 2006;118:137-44
4.Gasparoni A, Ciardelli L, Avanzini A, Castellazzi AM, Carini R, Rondini G, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate. 2003;84(4):297-303.
5.Bryan DL, Forsyth KD, Gibson RA, Hawkes JS. Interleukin-2 in human milk: a potential modulator of lymphocyte development in the breastfed infant. Cytokine. 2006;33:289-93.
6.Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7(5):379-90.
7.Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med. 2001;345(18):1331-5.
8.Hanson LÅ. Immunobiology of human milk. How breastfeeding protects babies. Amarillo, TX, USA: Pharmasoft Publ; 2004.
9.Siegrist CA. Neonatal and early life vaccinology. Vaccine. 2001;19(25-26):3331-46.
10. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21
(24):3406-12.
11.Siegrist CA. The challenges of vaccine responses in early life: selected examples. J Comp Pathol. 2007;137 Suppl 1:S4-9.
12.Rowe J, Poolman JT, Macaubas C, Sly PD, Loh R, Holt PG. Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody. Vaccine. 2004;22(29-30):3986-92.
13.Ada G. Vaccines and vaccination. N Engl J Med. 2001;345(14):1042-53.
14. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007;
204(10):2407-22.
15.Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, et al. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis. 2008;46
(2):186-92.
16.Silfverdal SA, Bodin L, Olcén P. Why the rise in Haemophilus influenzae type b infections? Lancet. 2003;362(9380):331.
17.Upham JW, Rate A, Rowe J, Kusel M, Sly PD, Holt PG. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun. 2006;74:1106-12.
18.Granoff DM, Pollard AJ. Reconsideration of the use of meningococcal polysaccharide vaccine. Pediatr Infect Dis J. 2007;26(8):716-22.
19.Briand V, Bonmarin I, Lévy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine. 2007;25(41):7224-32.
20.D'Angio CT. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.
Paediatr Drugs. 2007;9(1):17-32.
21.Olin P, Hallander, Gustafsson L, Barreto L, Podda A. Measuring protection; a case study of pertussis vaccines - Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination. Dev Biol Stand. 1998;
95:211-20.
22.Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109;
124-9.
23.Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, et al. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine. 2007;25(29):
5390-8.
24.Baynam G, Khoo SK, Rowe J, Zhang G, Laing I, Hayden C, et al. Parental smoking impairs vaccine responses in children with atopic genotypes. J Allergy Clin Immunol. 2007;119(2):
366-74.
25.Siebert JN, Posfay-Barbe KM, Habre W, Siegrist CA. Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidence. Paediatr Anaesth. 2007;17(5):410-20.
26.Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, et al. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics. 2008;121:e208-14.
27.Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol. 2007;137:S46-50.
28.Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J. 2007;26(11):
979-84.


 

1670

1671

1672

1673

1674